Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

BACKGROUND: Many smoking-cessation programs and pharmaceutical aids demonstrate substantial health gains for a relatively low allocation of resources. Genetic information represents a type of individualized or personal feedback regarding the risk of developing lung cancer, and hence the potential be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Louisa G, Hirst, Nicholas G, Young, Robert P, Brown, Paul M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949618/
https://www.ncbi.nlm.nih.gov/pubmed/20843376
http://dx.doi.org/10.1186/1478-7547-8-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949618/
https://www.ncbi.nlm.nih.gov/pubmed/20843376
http://dx.doi.org/10.1186/1478-7547-8-18

Ejemplares similares